IPG Health’s Laura Florence and Matt Hall explore the role of AI in pharma marketing

As AI’s influence on the healthcare marketing industry continues to evolve, Matt Hall, Executive Creative Director, Studio Rx, notes a particular impact on content production, with more clients willing to adopt AI tools.  

“In 2025, I believe a comfort level with proven tools and clear use cases will be established — such as derivative content creation — and AI will start to become a standard part of how we create those things,” Matt said. “This evolution will turn AI from a ‘special circumstance’ to a standard toolset, driving smarter and faster workflows.” 

Laura Florence, Chief Creative Officer, Rise & Run,  predicts AI will help make the diagnostic journey simpler. 

"For example, in oncology, AI could identify subtle patterns in imaging or genetic data to detect cancer earlier. In rare diseases, it could analyze disparate data points to uncover conditions that might otherwise go undiagnosed,” Laura said. “These advancements would enable faster, more accurate diagnoses and ultimately save lives.”